Clinical relevance of TRKA expression on neuroblastoma: comparison with N-MYC amplification and CD44 expression.


TRKA expression was evaluated on 122 untreated neuroblastomas by immunohistochemistry using an antibody with predetermined specificity. This procedure is simple and reliable for protein detection at cellular level in a routine clinical setting. Fourteen tumours were classified as benign ganglioneuroma with a restricted expression of TRKA on ganglion cells… (More)
DOI: 10.1038/bjc.1997.198


2 Figures and Tables